Endocrine |
|
|
Clinical Trial: Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients
This study is no longer recruiting patients.
Purpose
RATIONALE: Understanding the emotional needs of spouses or others who are living with and caring for patients who have undergone stem cell transplantation may help improve the quality of life of both the caregivers and the patients.
PURPOSE: Clinical trial to study the emotional needs of caregivers of patients who have undergone stem cell transplantation.
| Condition | Treatment or Intervention |
|---|---|
| Breast Cancer Endocrine Cancer female reproductive cancer hematopoietic and lymphoid cancer Neuroblastoma psychosocial effects and treatment | Procedure: psychosocial assessment/care Procedure: supportive care/therapy |
MedlinePlus related topics: Breast Cancer; Cancer; Cancer Alternative Therapy; Endocrine Diseases; Neuroblastoma; Reproductive Health
Genetics Home Reference related topics: breast cancer
Study Type: Interventional
Study Design: Treatment
Official Title: Study of Emotional Needs Among Caregivers of Post-Hematopoietic Stem Cell Transplantation Patients
OBJECTIVES:
- Assess expression of emotion, as a function of patient presence, among spousal or other cohabiting caregivers (CG) of post-hematopoietic stem cell transplantation patients.
- Assess desynchrony among subjective (self-report) and expressive indicators of emotion, as a function of patient presence, in these participants.
- Correlate CG dispositional inhibition and desynchrony with physical and marital satisfaction in these participants.
OUTLINE: Caregivers (CG) complete written questionnaires assessing demographics, positive and negative affect, dispositional inhibition, marital satisfaction, and physical health over 45 minutes to 1 hour on day 1. CG then engage in two oral emotional expression exercises (on the topic of caregiving and the transplant) over 2 hours on day 2. Patients are present for one oral emotional expression exercise.
Participants are followed at 2 weeks and 6 months.
PROJECTED ACCRUAL: A total of 60 patient/spouse couples will be accrued for this study within 18 months.
Eligibility
Ages Eligible for Study: 21 Years and above, Genders Eligible for Study: Both
Criteria
DISEASE CHARACTERISTICS:
- In a marriage OR long-term, committed, heterosexual or homosexual, cohabiting relationship in which one member is post-hematopoietic stem cell transplantation
- Patients must meet the following criteria:
- At least 1 year since prior first bone marrow, stem cell, or umbilical cord blood transplantation
- Allogeneic or autologous
- Diagnosis of malignancy, myelodysplasia, or non-malignancy
- No indication of possible or confirmed relapse
- Spouse/caregiver (CG) must meet the following criteria:
- Serve as the primary CG to the patient
- No prior or concurrent neurologic disorder
PATIENT CHARACTERISTICS: Age
- 21 and over
Performance status
- Not specified
Life expectancy
- Not specified
Hematopoietic
- Not specified
Hepatic
- Not specified
Renal
- Not specified
Other
- No concurrent major psychiatric disorder
- English-speaking
PRIOR CONCURRENT THERAPY: Biologic therapy
- See Disease Characteristics
Chemotherapy
- Not specified
Endocrine therapy
- Not specified
Radiotherapy
- Not specified
Surgery
- Not specified
Location Information
Shelby Langer, PhD, Principal Investigator, Fred Hutchinson Cancer Research Center
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database
Record last reviewed: November 2004
Last Updated: November 4, 2004
Record first received: May 14, 2004
ClinicalTrials.gov Identifier: NCT00082654
Health Authority: Unspecified
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Aromatherapy for the Glandular System (HealthWorld)
- Disorders of the Endocrine System (HealthWorld)

Not Signed In -


